New drug shown safe, effective in treating hereditary angioedema

Clinical trials from two international research teams have shown that icatibant, a new drug that blocks the action of an inflammatory protein known as bradykinin, is safe and effective in treating acute attacks of hereditary angioedema, a potentially life-threatening condition. In their report in the August 5 New England Journal of Medicine, the authors note that - while the results of one trial did not reach statistical significance - the drug is safe and effective and further study will help clarify the patients and symptoms best treated with icatibant.

Read the whole article on Physorg

More from Physorg